Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
A deep dive into the fees of four hospitals revealed that patients are paying as much as 2,100% more than distributors for some medical products.
Mesh will stay on the market in the U.K. while the government implements near- and long-term changes to protect patient safety.
Medical device maker Becton Dickinson is suing rival Cytek Biosciences and a group of former employees, claiming they stole trade secrets.
Banyan Biomarkers picked up the approval after showing the test reliably rules out intracranial lesions.
The FDA approved the use of Viz.AI’s artificial intelligence software that is designed to help quickly identify whether a patient has suffered a stroke.
Manufacturers including Abbott, Boston Scientific and Medtronic have argued that the ceiling makes their high-end products commercially unviable.
Abbott, Johnson & Johnson and 22 other organizations have told the FDA which medical device regulations they think the agency should scrap or revise.
The FDA and the Nuclear Regulatory Agency have cleared the use of NorthStar Medical’s RadioGenix system to produce technetium-99m.
Smith & Nephew, a London-based medical device maker, has launched its new single-use negative pressure wound system in the European market.
Empatica picked up an FDA 510(k) clearance for Embrace after the device detected every seizure in a 135-patient clinical trial.